PPARG and metabolic dysfunction-associated steatohepatitis: Nevertheless, PPARγ expressions in the liver were enhanced by genistein in both NASH + Gen8 and NASH + Gen16 groups with the significant increases of PPARγ immunoreactive cells (80.93 ± 7.36% in NASH + Gen8 group, p = 0.000, and 90.21 ± 7.57% in NASH + Gen16 group, p = 0.000).